Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

HUTCHMED (China) Limited (HCM)

Compare
15.90
-0.16
(-1.00%)
At close: 4:00:00 PM EDT
15.64
-0.26
(-1.64%)
After hours: 4:46:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
630,201
630,201
837,999
426,409
356,128
Cost of Revenue
348,884
348,884
384,447
311,103
258,234
Gross Profit
281,317
281,317
453,552
115,306
97,894
Operating Expense
321,927
321,927
432,043
521,565
425,893
Operating Income
-40,610
-40,610
21,509
-406,259
-327,999
Net Non Operating Interest Income Expense
37,208
37,208
35,386
8,947
1,484
Pretax Income
-1,107
-1,107
58,308
-410,422
-215,740
Tax Provision
7,192
7,192
4,509
-283
11,918
Net Income Common Stockholders
37,729
37,729
100,780
-360,835
-194,648
Diluted NI Available to Com Stockholders
37,729
37,729
100,780
-360,835
-194,648
Basic EPS
0.20
--
0.60
-2.15
-1.25
Diluted EPS
0.20
--
0.60
-2.15
-1.25
Basic Average Shares
171,070.34
--
169,930.86
169,428.71
158,536.91
Diluted Average Shares
174,565.83
--
173,839.27
169,428.71
158,536.91
Total Expenses
670,811
670,811
816,490
832,668
684,127
Net Income from Continuing & Discontinued Operation
37,729
37,729
100,780
-360,835
-194,648
Normalized Income
41,332
41,332
106,100.11
-358,736.09
-276,219.50
Interest Income
40,080
40,080
36,145
9,599
2,076
Interest Expense
2,872
2,872
759
652
592
Net Interest Income
37,208
37,208
35,386
8,947
1,484
EBIT
1,765
1,765
59,067
-409,770
-215,148
EBITDA
14,106
14,106
67,274
-401,106
-207,958
Reconciled Cost of Revenue
348,884
348,884
384,447
311,103
258,234
Reconciled Depreciation
12,341
12,341
8,207
8,664
7,190
Net Income from Continuing Operation Net Minority Interest
37,729
37,729
100,780
-360,835
-194,648
Total Unusual Items Excluding Goodwill
-4,804
-4,804
-5,766
-2,452
108,762
Total Unusual Items
-4,804
-4,804
-5,766
-2,452
108,762
Normalized EBITDA
18,910
18,910
73,040
-398,654
-316,720
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,201
-1,201
-445.89
-353.09
27,190.50
12/31/2021 - 3/16/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ALVO Alvotech
9.19
-4.67%
 
HLN Haleon plc
10.16
-0.20%
 
INDV Indivior PLC
9.52
+1.49%
 
ANIP ANI Pharmaceuticals, Inc.
69.36
+1.97%
 
NBIX Neurocrine Biosciences, Inc.
108.31
+1.22%
 
ITCI Intra-Cellular Therapies, Inc.
131.87
0.00%
 
ELAN Elanco Animal Health Incorporated
10.77
+4.06%
 
PRGO Perrigo Company plc
27.91
+0.76%
 
BHC Bausch Health Companies Inc.
6.11
-2.24%
 
AMRX Amneal Pharmaceuticals, Inc.
8.17
-0.73%